|
 | Up a level |
Najafi, A and Jolly, MK and George, JT (2024) Protocol for inferring epithelial-to-mesenchymal transition trajectories from single-cell RNA sequencing data using R. In: STAR Protocols, 5 (1).
Najafi, A and Jolly, MK and George, JT (2023) Population dynamics of EMT elucidates the timing and distribution of phenotypic intra-tumoral heterogeneity. In: iScience, 26 (7).
Masuda, H and Harano, K and Miura, S and Wang, Y and Hirota, Y and Harada, O and Jolly, MK and Matsunaga, Y and Lim, B and Wood, AL and Parinyanitikul, N and Lee, HJ and Gong, G and George, JT and Levine, H and Lee, J and Wang, X and Lucci, A and Rao, A and Schweitzer, BL and Lawrence, OR and Seitz, RS and Morris, SW and Hout, DR and Nakamura, S and Krishnamurthy, S and Ueno, NT (2022) Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy. In: JCO Precision Oncology, 6 .
Mandal, S and Tejaswi, T and Janivara, R and Srikrishnan, S and Thakur, P and Sahoo, S and Chakraborty, P and Sohal, SS and Levine, H and George, JT and Jolly, MK (2022) Transcriptomic-based quantification of the epithelial-hybrid-mesenchymal spectrum across biological contexts. In: Biomolecules, 12 (1).
Chakraborty, P and George, JT and Woodward, WA and Levine, H and Jolly, MK (2021) Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum. In: Translational Oncology, 14 (4).
Nihan Kilinc, A and Sugiyama, N and Reddy Kalathur, RK and Antoniadis, H and Birogul, H and Ishay-Ronen, D and George, JT and Levine, H and Kumar Jolly, M and Christofori, G (2020) Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial–mesenchymal plasticity and tumor metastasis. In: Oncogene, 39 (7). pp. 1498-1513.
Thankamony, AP and Murali, R and Karthikeyan, N and Varghese, BA and Teo, WS and McFarland, A and Roden, DL and Holliday, H and Konrad, CV and Cazet, A and Dodson, E and Yang, J and Baker, LA and George, JT and Levine, H and Jolly, MK and Swarbrick, A and Nair, R (2020) Targeting the id1-kif11 axis in triple-negative breast cancer using combination therapy. In: Biomolecules, 10 (9). pp. 1-15.
Chakraborty, P and George, JT and Tripathi, S and Levine, H and Jolly, MK (2020) Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum. In: Frontiers in Bioengineering and Biotechnology, 8 .
Lourenco, AR and Ban, Y and Crowley, MJ and Lee, SB and Ramchandani, D and Du, W and Elemento, O and George, JT and Jolly, MK and Levine, H and Sheng, J and Wong, ST and Altorki, NK and Gao, D (2020) Differential contributions of pre- And post-EMT tumor cells in breast cancer metastasis. In: Cancer Research, 80 (2). pp. 163-169.
Lourenco, AR and Ban, Y and Crowley, MJ and Lee, SB and Ramchandani, D and Du, W and Elemento, O and George, JT and Jolly, MK and Levine, H and Sheng, J and Wong, ST and Altorki, NK and Gao, D (2020) Differential contributions of pre- And post-EMT tumor cells in breast cancer metastasis. In: Cancer Research, 80 (2). pp. 163-169.
Jolly, MK and Ware, KE and Xu, S and Gilja, S and Shetler, S and Yang, Y and Wang, X and Austin, RG and Runyambo, D and Hish, AJ and DeWitt, SB and George, JT and Kreulen, RT and Boss, M-K and Lazarides, AL and Kerr, DL and Gerber, DG and Sivaraj, D and Armstrong, AJ and Dewhirst, MW and Eward, WC and Levine, H and Somarelli, JA (2019) E-cadherin represses anchorage-independent growth in sarcomas through both signaling and mechanical mechanisms. In: Molecular Cancer Research, 17 (6). pp. 1391-1402.
